First COMAC C919 Domestic Aircraft to be Delivered to China Eastern in December

The C919 is designed to compete with popular single-aisle models made by Airbus AIR.PA and Boeing BA.N.

Image Source : China Visual

Image Source : China Visual

BEIJING, October 26 (TMTPOST) — The first C919 aircraft will be delivered to China Eastern Airlines in December, Li Yangmin, the Vice Chairman and General Manager of the airlines said on Monday.

China Eastern will take on the responsibility as the first commercial operator of the C919 large passenger aircraft in China and ensure that it flies safely and efficiently. The C919 is designed to compete with popular single-aisle models made by Airbus AIR.PA and Boeing BA.N.

In 2021, China Eastern Airlines signed a contract with the C919 maker Commercial Aircraft Corporation of China (COMAC). The catalogue unit price of the C919 in the procurement contract is US$99 million (about RMB 721 million). The aircraft is expected to be put into use next year. According to COMAC data, the C919 has received 815 confirmed orders from 28 customers, including 34 orders from foreign buyers, with a total order value of over 500 billion yuan ($69.62 million).

The C919 is a 168-190-seat narrow-body mainline passenger aircraft developed by the COMAC, designed for short-to medium-haul routes. It is a single-aisle 150-seat aircraft with a seating capacity ranging between 168 and 190. It is also known as two-engine narrow-body aircraft for short and medium-distance transport.

The C919 aircraft is China's first single-aisle large mainline passenger aircraft developed in full compliance with international advanced airworthiness standards, with China's independent intellectual property rights. With a maximum range of more than 5,500 kilometres, its performance is comparable to the mainstream single-aisle passenger aircraft of the international new generation.

On May 14, 2022, the first flight test of the C919 aircraft, which will be delivered to the first user by COMAC, was successfully completed. On September 29, the Civil Aviation Administration of China (CAAC) officially issued the C919 aircraft type certificate to its manufacturer COMAC.

转载请注明出处、作者和本文链接
声明:文章内容仅供参考、交流、学习、不构成投资建议。
想和千万钛媒体用户分享你的新奇观点和发现,点击这里投稿 。创业或融资寻求报道,点击这里

敬原创,有钛度,得赞赏

赞赏支持
发表评论
0 / 300

根据《网络安全法》实名制要求,请绑定手机号后发表评论

登录后输入评论内容

快报

更多

18:22

CINNO Research:淡季叠加成本高企,2月手机面板价格全线下行

17:54

国际原油短线拉升,跌幅收窄至0.3%附近

17:53

天津市首笔“转型金融+碳配额履约”双挂钩认证贷款落地

17:52

礼来美股盘前涨近4%

17:43

诺和诺德美股盘前跌11%,CagriSema试验效果不及礼来的Zepbound

17:36

广州白云机场春运客流量突破500万

17:20

美股芯片半导体板块盘前走低,台积电、阿斯麦跌超1%

17:17

国投白银LOF:本基金将于2月24日开市起至当日10:30停牌

17:13

华大智造:拟5000万美元出售Complete Genomics公司100%股权并调整CoolMPS测序技术授权许可

17:12

美股加密货币概念股盘前走低,BMNR跌超3%

17:09

摩根大通:预计2026年第二季度铝均价为3200美元/吨,且下半年价格仍将获得有力支撑

17:04

德国总理默茨将访华

17:03

摩根大通:预估2026年铜市将出现13万吨供应缺口

16:59

科德数控:控股股东、实控人及总经理承诺未来6个月内不减持公司股份

16:59

亚士创能:控股股东所持公司2.9165%股份将被司法拍卖

16:55

南侨食品:公司实际控制人之一陈飞龙逝世

16:55

花旗:美股四季度业绩稳健,上调美股预期至市场共识上方

16:54

百利天恒:iza-bren(EGFR×HER3 双抗ADC)用于局部晚期或转移性三阴乳腺癌III 期临床试验的期中分析达到主要终点

16:52

前沿生物:与葛兰素史克签署授权许可协议,公司将获得4000万美元首付款及1300万美元近期里程碑付款

16:36

月之暗面近20天收入超去年全年

扫描下载App

Baidu
map